tm
Seeing Is Believing
tm
Seeing Is Believing
FIXX is currently covered by 7 analysts
Homology Medicines's activity chart (see below) currently has 20 price targets and 33 ratings on display. The stock rating distribution of FIXX is 53.33% BUY and 46.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 6.25% with an average time for these price targets to be met of 6.5 days.
Highest price target for FIXX is $3, Lowest price target is $1.
Most recent stock forecast was given by MADHU KUMAR from on 28-Jul-2023. First documented stock forecast 24-Apr-2018.
Currently out of the existing stock ratings of FIXX, 8 are a BUY (53.33%), 7 are a HOLD (46.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.5
$0.64 (74.42%)
$10
2 years 11 months 15 days ago
(28-Jul-2023)
1/8 (12.5%)
$0.17 (12.78%)
5
Buy
$20
$18.97 (1841.75%)
3 years 1 months 29 days ago
(15-May-2023)
0/1 (0%)
$18.98 (1860.78%)
Hold
$2
$1.14 (132.56%)
$3.21
3 years 2 months 1 days ago
(12-May-2023)
2/4 (50%)
$1.02 (104.08%)
60
Buy
$10
3 years 2 months 1 days ago
(12-May-2023)
0/3 (0%)
$7.96 (390.20%)
Buy
$7
3 years 3 months 7 days ago
(06-Apr-2023)
0/3 (0%)
$4.46 (175.59%)
What is FIXX (Homology Medicines) average time for price targets to be met?
Which analyst has the current highest performing score on FIXX (Homology Medicines) with a proven track record?
Which analyst has the most public recommendations on FIXX (Homology Medicines)?
Which analyst is the currently most bullish on FIXX (Homology Medicines)?
Which analyst is the currently most reserved on FIXX (Homology Medicines)?
